Biotech Exit: Million Arcellx Sparks Investor Reassessment
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Gain insights into the cash back credit card payout process to understand how and when you’ll receive your rewards.
16,809 articlesA notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
As four years after russia began its invasion, the war has sharpened economic stress on households and markets. Drone...
Analysts map a path for UPS through 2026 and beyond, highlighting margin resilience, volume growth, and cost control ...
As AI reshapes tech and business, where will Nvidia stock be in 2030? This guide breaks down drivers, risks, and prac...
Icon Amsterdam says 2025 was its best year yet after a broad restructuring, and it plans a phased U.S. entry in 2026,...
Dutch Bros is expanding fast and building a loyal customer base. Here are five practical reasons dutch bros stock cou...
Hollywood’s push to protect voice identity heats up as AI tools advance. Matthew McConaughey is leading a wave of tra...
Kanen Wealth Management added a substantial stake in Compass, prompting questions about compass stock after kanen. Th...
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Citigroup unveils a defensive blueprint to weather AI-led market swings, leaning on bonds and smaller-company stocks....
In early 2026, retirees are increasingly adopting a low-volatility ETF to stabilize portfolios amid ongoing market vo...
Tariffs are a powerful tool, but can they really replace the income tax? This analysis dives into the economics, data...